Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier de Leval

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry|October 11, 2005
Synthesis, molecular modelling and enzymatic evaluation of (+/-)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitorsMarie P Gauthier, Catherine Michaux, Stéphanie Rolin, et al.
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Journal of Medicinal Chemistry|May 14, 2004
Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivityXavier de Leval, Monica Ilies, Angela Casini, et al.
Journal of Medicinal Chemistry|December 24, 2004
Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitorsFabien Julémont, Xavier de Leval, Catherine Michaux, et al.
Journal of Medicinal Chemistry|March 18, 2005
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moietiesJean-Yves Winum, Jean-Michel Dogné, Angela Casini, et al.
Biochemical and Biophysical Research Communications|November 24, 2004
Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1)Ange Mouithys-Mickalad, Ginette Deby-Dupont, Jean-Michel Dogne, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulatorsJean-Michel Dogné, Xavier de Leval, Julien Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004
Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding timeJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry|October 11, 2005
Synthesis, molecular modelling and enzymatic evaluation of (+/-)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitorsMarie P Gauthier, Catherine Michaux, Stéphanie Rolin, et al.
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Journal of Medicinal Chemistry|May 14, 2004
Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivityXavier de Leval, Monica Ilies, Angela Casini, et al.
Journal of Medicinal Chemistry|December 24, 2004
Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitorsFabien Julémont, Xavier de Leval, Catherine Michaux, et al.
Journal of Medicinal Chemistry|March 18, 2005
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moietiesJean-Yves Winum, Jean-Michel Dogné, Angela Casini, et al.
Biochemical and Biophysical Research Communications|November 24, 2004
Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1)Ange Mouithys-Mickalad, Ginette Deby-Dupont, Jean-Michel Dogne, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulatorsJean-Michel Dogné, Xavier de Leval, Julien Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004
Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding timeJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Pageof 3